Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

757

Figures (1-9)

147

Tables (1-1)

136

Sum=1087

Publishing Process of This Article

Item

Count

Browse

Download

271

Sum=329

Apr 15, 2024 (publication date) through Nov 13, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1564-1577
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1564

Table 1 A summary of colorectal cancer microarray dataset from Gene Expression Omnibus dataset

	Series	Platform	Affymetrix GeneChip	Sensitive	Resistant
1	GSE42387	GPL16297	Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Agilent Systematic Name, collapsed probe, version)	9	9
2	GSE30011	GPL2006	Human 19K oligo array	14	14

Citation: Li SN, Yang S, Wang HQ, Hui TL, Cheng M, Zhang X, Li BK, Wang GY. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription. World J Gastrointest Oncol 2024; 16(4): 1564-1577
URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1564.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1564